Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention

NCT01530490 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Complications Associated With Artificial Fertilization
Disorder of Endocrine Ovary

Interventions

DRUG: Cabergoline and Hydroxyethyl Starch
DRUG: Hydroxyethyl Starch

Sponsor

Hospital de Cruces